Published in J Med Case Rep on October 18, 2011
DNA methylation and gene deletion analysis of brain metastases in melanoma patients identifies mutually exclusive molecular alterations. Neuro Oncol (2014) 1.10
Identification of hypermethylation in hepatocyte cell adhesion molecule gene promoter region in bladder carcinoma. Int J Med Sci (2013) 0.79
Epigenetic alterations in a gastric leiomyoma. Case Rep Gastrointest Med (2014) 0.75
The epigenomics of cancer. Cell (2007) 30.91
Methylation of the estrogen receptor gene CpG island marks loss of estrogen receptor expression in human breast cancer cells. Cancer Res (1994) 3.18
DNA methylation in breast and colorectal cancers. Mod Pathol (2007) 2.88
Methylation of estrogen and progesterone receptor gene 5' CpG islands correlates with lack of estrogen and progesterone receptor gene expression in breast tumors. Clin Cancer Res (1996) 1.77
Wilms' tumor suppressor gene (WT1) is expressed in primary breast tumors despite tumor-specific promoter methylation. Cancer Res (2001) 1.73
Giant fibroadenoma of the breast in adolescents: report of 2 cases. J Pediatr Surg (2009) 1.24
p16(INK4a) promoter methylation and protein expression in breast fibroadenoma and carcinoma. Int J Cancer (2005) 1.10
Abnormal regulation of the oestrogen receptor in benign breast lesions. J Clin Pathol (2000) 1.01
Pattern of expression of genes linked to epigenetic silencing in human breast cancer. Hum Pathol (2006) 0.97
Promoter- and cell-specific epigenetic regulation of CD44, Cyclin D2, GLIPR1 and PTEN by methyl-CpG binding proteins and histone modifications. BMC Cancer (2010) 0.96
Simultaneous analysis of the methylation profile of 26 cancer related regions in invasive breast carcinomas by MS-MLPA and drMS-MLPA. Mol Cell Probes (2010) 0.90
Prognostic value of Bcl-2 in breast cancer patients treated with neoadjuvant anthracycline based chemotherapy. Mol Oncol (2008) 0.88
Carcinoma developing in a fibroadenoma in a woman with a family history of breast cancer: a case report and review of literature. Cases J (2009) 0.82
Methylation status of CpG islands at sites -59 to +96 in exon 1 of the BRCA2 gene varies in mammary tissue among women with sporadic breast cancer. J Genet (2008) 0.80
Determination of estrogen receptor in primary breast cancer using two different monoclonal antibodies, and correlation with its mRNA expression. Pathol Int (1999) 0.80
Stromal cell expression of caveolin-1 predicts outcome in breast cancer. Am J Pathol (2009) 2.44
Co-expression of steroid receptors (estrogen receptor alpha and/or progesterone receptors) and Her-2/neu: Clinical implications. J Steroid Biochem Mol Biol (2006) 1.09
Hsp27 as a prognostic and predictive factor in cancer. Prog Mol Subcell Biol (2002) 1.06
P-cadherin and beta-catenin are useful prognostic markers in breast cancer patients; beta-catenin interacts with heat shock protein Hsp27. Cell Stress Chaperones (2008) 1.01
Asymptomatic Becker muscular dystrophy in a family with a multiexon deletion. Muscle Nerve (2009) 1.00
DNA damage and repair in peripheral blood lymphocytes from healthy individuals and cancer patients: a pilot study on the implications in the clinical response to chemotherapy. Cancer Lett (2005) 0.91
Simultaneous analysis of the methylation profile of 26 cancer related regions in invasive breast carcinomas by MS-MLPA and drMS-MLPA. Mol Cell Probes (2010) 0.90
Prognostic value of Bcl-2 in breast cancer patients treated with neoadjuvant anthracycline based chemotherapy. Mol Oncol (2008) 0.88
Deoxyribonucleic acid damage induced by doxorubicin in peripheral blood mononuclear cells: possible roles for the stress response and the deoxyribonucleic acid repair process. Cell Stress Chaperones (2003) 0.86
DNA methylation index and methylation profile of invasive ductal breast tumors. J Mol Diagn (2012) 0.86
Effects of hyperthermia on Hsp27 (HSPB1), Hsp72 (HSPA1A) and DNA repair proteins hMLH1 and hMSH2 in human colorectal cancer hMLH1-deficient and hMLH1-proficient cell lines. Int J Hyperthermia (2012) 0.80
MLPA mutation detection in Argentine HNPCC and FAP families. Fam Cancer (2008) 0.79
Hsp27, Hsp70 and mismatch repair proteins hMLH1 and hMSH2 expression in peripheral blood lymphocytes from healthy subjects and cancer patients. Cancer Lett (2007) 0.78
Prognostic implication of HSPA (HSP70) in breast cancer patients treated with neoadjuvant anthracycline-based chemotherapy. Cell Stress Chaperones (2013) 0.77
HER2 and β-catenin protein location: importance in the prognosis of breast cancer patients and their correlation when breast cancer cells suffer stressful situations. Clin Exp Metastasis (2015) 0.77
Development of a Premature Stop Codon-detection method based on a bacterial two-hybrid system. BMC Biotechnol (2006) 0.77
Epigenetic variations in breast cancer progression to lymph node metastasis. Clin Exp Metastasis (2015) 0.76
Polymorphism of the FABP2 gene: a population frequency analysis and an association study with cardiovascular risk markers in Argentina. BMC Med Genet (2007) 0.75
In MMTV-Her-2/neu transgenic mammary tumors the absence of caveolin-1-/- alters PTEN and NHERF1 but not β-catenin expression. Cell Stress Chaperones (2013) 0.75
[Neurofibromatosis type 1. Splicing mutation detected by MLPA and DNA sequencing in Argentina]. Medicina (B Aires) (2015) 0.75
Hyperthermia effects on Hsp27 and Hsp72 associations with mismatch repair (MMR) proteins and cisplatin toxicity in MMR-deficient/proficient colon cancer cell lines. Int J Hyperthermia (2015) 0.75
[Detection of a founder mutation in an Argentine family with hereditary non polyposis colorectal cancer]. Medicina (B Aires) (2010) 0.75
[Detection of a non-standard mutation in the ret protoncogene by site directed mutagenesis]. Medicina (B Aires) (2005) 0.75
[Detection of a Williams Beuren syndrome case by MLPA]. Medicina (B Aires) (2013) 0.75